Cargando…

Answering the Big Clinical Questions in Brain Metastasis Management

Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors f...

Descripción completa

Detalles Bibliográficos
Autor principal: Kirkpatrick, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805701/
https://www.ncbi.nlm.nih.gov/pubmed/35118002
http://dx.doi.org/10.3389/fonc.2021.834122
_version_ 1784643283491749888
author Kirkpatrick, John P.
author_facet Kirkpatrick, John P.
author_sort Kirkpatrick, John P.
collection PubMed
description Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors face in the clinic. Successfully answering these questions requires knowledge of the clinical evidence, thoughtful discussion of the patient’s goals of care and collaboration in a multi-disciplinary setting.
format Online
Article
Text
id pubmed-8805701
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88057012022-02-02 Answering the Big Clinical Questions in Brain Metastasis Management Kirkpatrick, John P. Front Oncol Oncology Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors face in the clinic. Successfully answering these questions requires knowledge of the clinical evidence, thoughtful discussion of the patient’s goals of care and collaboration in a multi-disciplinary setting. Frontiers Media S.A. 2022-01-18 /pmc/articles/PMC8805701/ /pubmed/35118002 http://dx.doi.org/10.3389/fonc.2021.834122 Text en Copyright © 2022 Kirkpatrick https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kirkpatrick, John P.
Answering the Big Clinical Questions in Brain Metastasis Management
title Answering the Big Clinical Questions in Brain Metastasis Management
title_full Answering the Big Clinical Questions in Brain Metastasis Management
title_fullStr Answering the Big Clinical Questions in Brain Metastasis Management
title_full_unstemmed Answering the Big Clinical Questions in Brain Metastasis Management
title_short Answering the Big Clinical Questions in Brain Metastasis Management
title_sort answering the big clinical questions in brain metastasis management
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805701/
https://www.ncbi.nlm.nih.gov/pubmed/35118002
http://dx.doi.org/10.3389/fonc.2021.834122
work_keys_str_mv AT kirkpatrickjohnp answeringthebigclinicalquestionsinbrainmetastasismanagement